IFIH1 and dermatomyositis: Although studies on MDA5 expression in these target tissues are very rare, MDA5 expression has been shown to be enhanced in skin biopsies of patients with DM, which could offer an element of response to the severe cutaneous symptoms associated with the disease (79).